TY - JOUR
T1 - Balloon-Expandable Versus Self-Expanding Valves in Patients With Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement
AU - Hemelrijk, Kimberley Iris
AU - Broeze, Gijs Matthias
AU - Aarts, Hugo Marc
AU - Garcia, Erika Muñoz
AU - Tchétché, Didier
AU - de Brito, Fabio Sandoli
AU - Barbanti, Marco
AU - Kornowski, Ran
AU - Latib, Azeem
AU - Onofrio, Augusto D’
AU - Ribichini, Flavio
AU - Cid, Belen
AU - Dumonteil, Nicolas
AU - Abizaid, Alexandre
AU - Sartori, Samantha
AU - D’Errigo, Paola
AU - Tarantini, Giuseppe
AU - Vigo, Cesar Federico
AU - Orvin, Katia
AU - Pagnesi, Matteo
AU - Valle-Fernandez, Raquel del
AU - Dangas, George
AU - Mehran, Roxana
AU - van Nieuwkerk, Astrid Cornelia
AU - Delewi, Ronak
N1 - Publisher Copyright:
© 2026 Published by Elsevier Inc.
PY - 2026/9/1
Y1 - 2026/9/1
N2 - Transcatheter aortic valve replacement (TAVR) is a widely accepted treatment option for patients with severe aortic valve stenosis. However, approximately one-third of patients undergoing TAVR present with a small aortic annulus, which is associated with impaired valve performance. The primary objective of this study was to evaluate 2-year mortality after transfemoral TAVR in patients with a small aortic annulus (valve size ≤23 mm for balloon-expandable valves and ≤26 mm for self-expanding valves), comparing balloon-expandable with self-expanding valves. The CENTER2-study includes data from 25,771 patients undergoing TVR. Patients were propensity score-matched and compared on clinical outcomes. A total of 8,827 (37.2%) patients had a small aortic annulus. Mean age was 81.9 ± 6.3 years, 76.9% were female, and the median STS-PROM score was 4.8% (IQR 2.3 to 5.6). In the matched cohort of 2,692 patient pairs, patients receiving a balloon-expandable valve had higher rates of life-threatening bleeding at 30 days (3.6% vs 2.4%, p = 0.01) and two-year mortality (19.1% vs 15.3%, HR 1.23, 95% CI 1.07 to 1.43, p = 0.004). However, permanent pacemaker implantation was more frequent in patients receiving a self-expanding valve (21.6% vs 8.7%, p < 0.001). In conclusion, in this large real-world cohort of patients undergoing transfemoral TAVR, 37.2% of patients had a small aortic annulus. Patients with a small aortic annulus receiving a balloon-expandable valve had higher 2-year mortality rates. Patients receiving a self-expanding valve had higher rates of permanent pacemaker implantation.
AB - Transcatheter aortic valve replacement (TAVR) is a widely accepted treatment option for patients with severe aortic valve stenosis. However, approximately one-third of patients undergoing TAVR present with a small aortic annulus, which is associated with impaired valve performance. The primary objective of this study was to evaluate 2-year mortality after transfemoral TAVR in patients with a small aortic annulus (valve size ≤23 mm for balloon-expandable valves and ≤26 mm for self-expanding valves), comparing balloon-expandable with self-expanding valves. The CENTER2-study includes data from 25,771 patients undergoing TVR. Patients were propensity score-matched and compared on clinical outcomes. A total of 8,827 (37.2%) patients had a small aortic annulus. Mean age was 81.9 ± 6.3 years, 76.9% were female, and the median STS-PROM score was 4.8% (IQR 2.3 to 5.6). In the matched cohort of 2,692 patient pairs, patients receiving a balloon-expandable valve had higher rates of life-threatening bleeding at 30 days (3.6% vs 2.4%, p = 0.01) and two-year mortality (19.1% vs 15.3%, HR 1.23, 95% CI 1.07 to 1.43, p = 0.004). However, permanent pacemaker implantation was more frequent in patients receiving a self-expanding valve (21.6% vs 8.7%, p < 0.001). In conclusion, in this large real-world cohort of patients undergoing transfemoral TAVR, 37.2% of patients had a small aortic annulus. Patients with a small aortic annulus receiving a balloon-expandable valve had higher 2-year mortality rates. Patients receiving a self-expanding valve had higher rates of permanent pacemaker implantation.
KW - TAVR
KW - aortic stenosis
KW - small aortic annulus
UR - https://www.scopus.com/pages/publications/105045176155
U2 - 10.1016/j.amjcard.2026.06.021
DO - 10.1016/j.amjcard.2026.06.021
M3 - Article
C2 - 42362006
AN - SCOPUS:105045176155
SN - 0002-9149
VL - 274
SP - 44
EP - 50
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -